INVO Reports Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall St gains on chip stocks recovery; earnings draw focus
- Oil prices rise to five-week high on US-Iran attacks, Houthi blockade threat
- Chip stocks extend global rebound following last week's rout
- Citi's Chew says U.S. stock positioning unwind may not be over
- Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
INVO Bioscience (INVO) Tops Q2 EPS by 14c
August 14, 2023 4:20 PM EDTINVO Bioscience (NASDAQ: INVO) reported Q2 EPS of ($3.06), $0.14 better than the analyst estimate of ($3.20). Revenue for the quarter came in at $315.9 thousand versus the consensus estimate of $517 thousand.
For earnings history and earnings-related data on INVO Bioscience (INVO) click here.
... More